J. A. Goas

3.4k total citations · 2 hit papers
10 papers, 2.6k citations indexed

About

J. A. Goas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. A. Goas has authored 10 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. A. Goas's work include Bone health and treatments (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). J. A. Goas is often cited by papers focused on Bone health and treatments (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). J. A. Goas collaborates with scholars based in Canada, United States and Australia. J. A. Goas's co-authors include Louis Lacombe, Robin Murray, Fred Saad, Donald M. Gleason, Joseph L. Chin, P. Venner, Simon Tchekmedyian, J. Vinholes, J.L. Chin and Reginald L. Dean and has published in prestigious journals such as Science, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

J. A. Goas

10 papers receiving 2.5k citations

Hit Papers

A Randomized, Placebo-Controlled Trial of Zoledronic Acid... 2002 2026 2010 2018 2002 2004 400 800 1.2k

Peers

J. A. Goas
Stuart C. Apfel United States
Mary Ann C. Sabino United States
Jae‐Kyu Roh South Korea
Jar-Chi Lee United States
Zoltán Patay United States
M. Chatel France
Roger A Fisken United Kingdom
Stuart C. Apfel United States
J. A. Goas
Citations per year, relative to J. A. Goas J. A. Goas (= 1×) peers Stuart C. Apfel

Countries citing papers authored by J. A. Goas

Since Specialization
Citations

This map shows the geographic impact of J. A. Goas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Goas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Goas more than expected).

Fields of papers citing papers by J. A. Goas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Goas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Goas. The network helps show where J. A. Goas may publish in the future.

Co-authorship network of co-authors of J. A. Goas

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Goas. A scholar is included among the top collaborators of J. A. Goas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Goas. J. A. Goas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tchekmedyian, Simon, et al.. (2004). Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer. JNCI Journal of the National Cancer Institute. 96(11). 879–882. 891 indexed citations breakdown →
2.
Saad, Fred, Donald M. Gleason, Robin Murray, et al.. (2004). 615 Long-term efficacy and safety of zoledronic acid in men with advanced prostate cancer and bone metastases. European Urology Supplements. 3(2). 156–156. 11 indexed citations
3.
Saad, Fred, et al.. (2003). RESPONSE: Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma. JNCI Journal of the National Cancer Institute. 95(4). 333–334. 2 indexed citations
4.
Saad, Fred, Donald M. Gleason, Robin Murray, et al.. (2002). A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma. JNCI Journal of the National Cancer Institute. 94(19). 1458–1468. 1242 indexed citations breakdown →
5.
Berenson, James, et al.. (2000). Phase II trial of zoledronate versus pamidronate in multiple myeloma and breast carcinoma patients with osteolytic lesions. Cancer. 88(12). 310215. 1 indexed citations
6.
Dean, Reginald L., et al.. (1981). Age-related differences in behavior across the life span of the C57BL/6J mouse. Experimental Aging Research. 7(4). 427–451. 163 indexed citations
7.
Bartus, Raymond T., Reginald L. Dean, J. A. Goas, & Arnold Lippa. (1980). Age-Related Changes in Passive Avoidance Retention: Modulation with Dietary Choline. Science. 209(4453). 301–303. 219 indexed citations
8.
Goas, J. A., Russell W. Pelham, & Arnold Lippa. (1979). Endocrine factors contributing to the ethanol preferences of rodents. Pharmacology Biochemistry and Behavior. 10(4). 557–560. 13 indexed citations
9.
Goas, J. A., Arnold Lippa, & Russell W. Pelham. (1978). Endocrine factors underlying the ethanol preference of c57bl/6j mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 421. 1 indexed citations
10.
Goas, J. A. & Arnold Lippa. (1978). Bimodal distributions of highest ethanol acceptance concentrations in two strains of rats. Pharmacology Biochemistry and Behavior. 8(6). 695–699. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026